Skip to main content

Inspire® therapy qualifications

More than 100,0001 people with obstructive sleep apnea (OSA) have pursued restful sleep with Inspire® therapy.

Eligibility requirements

To be a candidate for Inspire therapy, you must meet the following FDA indications:

  • Age 18 or older​

  • Diagnosed with moderate to severe obstructive sleep apnea​

  • Unable to benefit from CPAP

Inspire therapy has been clinically tested for people with a body mass index (BMI) up to 40. Over 90%2 of U.S. adults are within this range. Most insurance policies have a BMI policy in place for Inspire therapy coverage. Talk to your provider or Inspire therapy-trained doctor for more information.

Inspire therapy is FDA-approved for use in pediatric patients with Down syndrome. Learn more about specific qualifications here.

Do you qualify?

Find out if Inspire therapy is right for you. Most people who have tried and struggle with CPAP meet the basic requirements for Inspire therapy. 


Take the quiz

Next generation.
​Same proven results. ​

Experience the next generation of the Inspire® implant, designed for enhanced patient comfort and a shorter, simplified procedure3 – available now through many Inspire-trained providers across the country.​

Real patients recommend Inspire therapy

Ambassador Emily
Ambassador Scott
Ambassador Pete
Ambassador Emily

“I’m doing more outdoor activities. I’m able to go to the gym more. And it feels better.”

Emily

Inspire Day: September 28th, 2020

Ambassador Scott

“The incisions themselves are honestly not that big, I hardly see them.”

Scott Raymond

Inspire Day: November 17th, 2020

Ambassador Pete

“The freedom that we have because all we have to carry with us is this little remote!”

Pete & Gwen

Inspire Day: October 1st, 2018

1 of 3

Ready to make a consultation appointment?

Your primary care provider can refer you to an Inspire-trained provider for a consultation. You also can reach out to an Inspire Advisor or use the locator to find one near you.

Find a doctor
1 Data on file.
2 “Overweight & Obesity Statistics - Niddk.” National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Department of Health and Human Services, Sept. 2021.
3 Huyett P, Suurna MV. Lateral Axillary Approach for Placement of the Fifth-Generation Hypoglossal Nerve Stimulator Implantable Pulse Generator. Otolaryngol Head Neck Surg. 2025 May 21. doi: 10.1002/ohn.1321. Epub ahead of print. PMID: 40396442.| SLR Han, et al. Preliminary Results of a Next-Generation Hypoglossal Nerve Stimulation Therapy for the Treatment of Obstructive Sleep Apnea. Poster - AASM 2025
The patient testimonials & sleep apnea treatment reviews above relate to accounts of an individual’s response to treatment. The accounts are genuine, typical & documented. Responses to the treatment can & do vary. Not every response is the same. Patients were not compensated other than for travel expenses. Please review the safety information provided on this site & note that this therapy is not for everyone. Furthermore, the information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.
801-050-000, Rev AL